Ondansetron Injection
Product Images NDC 86211-115

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 86211-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jvet Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Carton (Carton)
This is a description of Ondansetron Injection, USP, with a strength of 40 mg/20 mL (2mg/mL). It is intended for intravenous or intramuscular injection. The product is distributed by Jvet Pharmaceuticals LLC and is made in India. Each 1 mL of the solution contains Ondansetron 2 mg as Ondansetron hydrochloride dihydrate, along with other ingredients such as buffers and preservatives. The package insert provides detailed information on dosage and administration. It is recommended to store the product at 20°C to 25°C and protect from light. The medication comes in a sterile 20 mL multi-dose vial for prescription use only.*
FDA Label Image

Ondansetron-spl-structure (Ondansetron Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.